ALEJANDRO
MOLINA LEYVA
DOCENTE INVITADO
![Foto de ALEJANDRO](/img/nophoto.png)
![Foto de Hospital de la Santa Creu i Sant Pau](/img/noimage_org.png)
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (4)
2024
-
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study
Australasian Journal of Dermatology
2023
-
Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”
Journal of the American Academy of Dermatology
2020
-
Ustekinumab with intravenous infusion: Results in hidradenitis suppurativa
Dermatology, Vol. 236, Núm. 1, pp. 21-24
2019
-
Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes
Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1455-1457